The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. China Pharma Holding's quick ratio for the quarter that ended in Dec. 2023 was 0.33.
China Pharma Holding has a quick ratio of 0.33. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for China Pharma Holding's Quick Ratio or its related term are showing as below:
CPHI'
s Quick Ratio Range Over the Past 10 Years
Min: 0.14 Med: 0.46 Max: 1.88
Current: 0.33
During the past 13 years, China Pharma Holding's highest Quick Ratio was 1.88. The lowest was 0.14. And the median was 0.46.
CPHI's Quick Ratio is ranked worse than 89.85% of 1074
companies
in the Drug Manufacturers industry
Industry Median: 1.33
vs CPHI: 0.33
China Pharma Holding Quick Ratio Historical Data
The historical data trend for China Pharma Holding's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of China Pharma Holding's Quick Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, China Pharma Holding's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Pharma Holding's Quick Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China Pharma Holding's Quick Ratio distribution charts can be found below:
* The bar in red indicates where China Pharma Holding's Quick Ratio falls into.
China Pharma Holding Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
China Pharma Holding's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Pharma Holding (OTCPK:CPHI) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
China Pharma Holding Quick Ratio Related Terms
Thank you for viewing the detailed overview of China Pharma Holding's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
China Pharma Holding (China Pharma Holding) Business Description
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CPHI has been successfully added to your 